Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 54,196 shares at $30.08 ($1.6M) on 2025-01-23, disclosed to the SEC on 2025-01-24.
Scheduled sale ($1.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.08 | 27,098 | $815K | 50.0% |
| 2 | $30.08 | 27,098 | $815K | 50.0% |
| Total | $30.08 avg | 54,196 | $1.6M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |